Life Sciences Partners, Ysios Capital, Sunstone Capital and Flerie Invest have led a €32m investment round for Swedish drug developer Oxthera.
Deal will enable the online booking platform to expand its operations team and prepare for a US launch
Acquirer is currently investing from its sixth flagship fund, which writes equity cheques of €100-300m
GP buys a 70% stake in insurance business Groupe Premium, investing alongside management
Company will use the fresh capital to support the launch of its new Atlas motorcycle helmet